Richard D. Schulick

University of Colorado Anschutz Medical Campus

Papers

2

Total Citations

196

H-Index

2

About

Richard D. Schulick is a leading figure in surgical oncology, renowned for his expertise in hepatopancreaticobiliary (HPB) surgery and his pivotal role in advancing minimally invasive approaches for complex abdominal cancers. His major contributions center on rigorously evaluating the safety, oncologic efficacy, and economic implications of laparoscopic and robotic techniques compared to traditional open surgery. A landmark study, cited over 159 times, leveraged the National Cancer Database to compare short-term and oncologic outcomes of minimally invasive versus open pancreaticoduodenectomy across low and high-volume centers, providing crucial evidence on the procedure's viability and the importance of institutional experience. Further demonstrating his commitment to evidence-based practice, his systematic review and meta-analysis on the economic analysis of open, laparoscopic, and robotic hepatectomy (cited 37 times) offers vital insights into cost-effectiveness. As a prolific researcher and former Chair of Surgery at the University of Colorado, Schulick’s work has profoundly shaped surgical standards, guiding clinical decision-making and training for the next generation of HPB surgeons.

Research Focus

Key Achievements

2
H-Index
2
Papers
196
Total Citations
98
Avg Citations/Paper
🏆 Most Cited Paper
Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers
159 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: University of Colorado Anschutz Medical Campus

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago